IRONWOOD PHARMACEUTICALS ($IRWD) posted quarterly earnings results for Q4 2025 on Wednesday, February 25th. The company reported earnings of -$0.01 per share, missing estimates of $0.01 by $0.02. The company also reported revenue of $47,710,000, missing estimates of $51,951,996 by $-4,241,996.
You can see Quiver Quantitative's $IRWD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
IRONWOOD PHARMACEUTICALS Insider Trading Activity
IRONWOOD PHARMACEUTICALS insiders have traded $IRWD stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $IRWD stock by insiders over the last 6 months:
- RONALD SILVER (Principal Accounting Officer) sold 35,416 shares for an estimated $162,913
- TAMMI L GASKINS (Chief Commercial Officer) sold 6,016 shares for an estimated $19,973
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
IRONWOOD PHARMACEUTICALS Hedge Fund Activity
We have seen 116 institutional investors add shares of IRONWOOD PHARMACEUTICALS stock to their portfolio, and 82 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KYNAM CAPITAL MANAGEMENT, LP removed 5,466,825 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $18,423,200
- MARSHALL WACE, LLP added 1,279,863 shares (+40.7%) to their portfolio in Q4 2025, for an estimated $4,313,138
- STATE STREET CORP added 1,254,915 shares (+39.8%) to their portfolio in Q4 2025, for an estimated $4,229,063
- FEDERATED HERMES, INC. added 1,161,033 shares (+53.8%) to their portfolio in Q4 2025, for an estimated $3,912,681
- HILLSDALE INVESTMENT MANAGEMENT INC. added 1,156,378 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,896,993
- QUBE RESEARCH & TECHNOLOGIES LTD removed 1,125,681 shares (-40.1%) from their portfolio in Q4 2025, for an estimated $3,793,544
- LAZARD ASSET MANAGEMENT LLC added 1,000,445 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,371,499
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
IRONWOOD PHARMACEUTICALS Price Targets
Multiple analysts have issued price targets for $IRWD recently. We have seen 2 analysts offer price targets for $IRWD in the last 6 months, with a median target of $6.5.
Here are some recent targets:
- Jason Butler from Citizens set a target price of $8.0 on 01/05/2026
- Mohit Bansal from Wells Fargo set a target price of $5.0 on 01/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
